Nils Siegbahn

Nils Siegbahn currently works at Sparbanksstiftelsen Skånes Riskkapitalstiftelse, as Director.
Dr. Siegbahn also formerly worked at Pernovo AB, as Chief Executive Officer, Glycorex Transplantation AB, as Chairman from 2000 to 2009, Atos Medical AB, as Director, Perstorp Holding AB, as Director-Special Projects, Celltrix AB, as Director, Niconovum AB, as Managing Director, Enzymatica AB, as Independent Director from 2015 to 2016, Glycorex Transplantation AB, as Director, and Alligator Bioscience AB, as President from 2000 to 2004.
Dr. Siegbahn received his graduate degree from Stockholm School of Economics and doctorate degree from Faculty of Engineering, Lund University.